← back to search

Yanan Zheng

University of California, Davis · US
Area of research
Pulmonary and Respiratory Medicine · Gastroenterology
Research interest
Research interests include Medicine, Biosensor, Mercury (programming language), Periostin, Placebo, and Asthma.
h-index
citations
1,513
works
16
NIH funding
primary concept
email

Recent publications

Pathologic Response of Phase III Study: Perioperative Camrelizumab Plus Rivoceranib and Chemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer (DRAGON IV/CAP 05)
Journal of Clinical Oncology 2024cited by 42position: middledoi
GPT understands, too
AI Open 2023cited by 75position: middledoi
Fully‐Printed Bionic Tactile E‐Skin with Coupling Enhancement Effect to Recognize Object Assisted by Machine Learning
Advanced Functional Materials 2023cited by 34position: middledoi
Distinguished biomimetic <scp>dECM</scp> system facilitates early detection of metastatic breast cancer cells
Bioengineering & Translational Medicine 2023cited by 9position: middledoi
Exosome-based delivery nanoplatforms: next-generation theranostic platforms for breast cancer
Biomaterials Science 2022cited by 28position: firstdoi
Research on the Relationship between Empathy, Belief in a Just World, and Childhood Trauma in Pre-Clinical Medical Students
Healthcare 2022cited by 6position: firstdoi
Rapid field testing of mercury pollution by designed fluorescent biosensor and its cells-alginate hydrogel-based paper assay
Journal of Environmental Sciences 2021cited by 16position: firstdoi
Review and outlook on the international renewable energy development
Energy and Built Environment 2020cited by 417position: middledoi
Osteoblast/fibroblast coculture derived bioactive ECM with unique matrisome profile facilitates bone regeneration
Bioactive Materials 2020cited by 61position: middledoi
A signal-amplified whole-cell biosensor for sensitive detection of Hg2+ based on Hg2+-enhanced reporter module
Journal of Environmental Sciences 2020cited by 16position: middledoi
Visual detection of Hg2+ by manipulation of pyocyanin biosynthesis through the Hg2+-dependent transcriptional activator MerR in microbial cells
Journal of Bioscience and Bioengineering 2019cited by 39position: middledoi
Engineered cells for selective detection and remediation of Hg2+ based on transcription factor MerR regulated cell surface displayed systems
Biochemical Engineering Journal 2019cited by 17position: middledoi
Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle
Clinical Pharmacology & Therapeutics 2018cited by 88position: middledoi
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Thorax 2015cited by 376position: middledoi
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge
Clinical & Experimental Allergy 2013cited by 126position: middledoi
A Guide to Rational Dosing of Monoclonal Antibodies
Clinical Pharmacokinetics 2012cited by 163position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Qi Xiao · Ningbo University3 papers (2019–2020)Haijiao Mao · Ningbo University3 papers (2020–2023)Xiaosu Fan · Guangxi University3 papers (2019–2020)Dan Wang · Guangxi University3 papers (2019–2020)Shan Huang · Nanchang University3 papers (2019–2020)Jiyuan Zhao · Ningbo University3 papers (2020–2023)Na Wei · Tianjin University of Traditional Chinese Medicine2 papers (2019–2020)Heleen Scheerens · Gene Therapy Laboratory2 papers (2013–2015)Lina Xu · Tianjin Chest Hospital2 papers (2019–2019)Liudan Wei · Guangzhou Medical University2 papers (2020–2021)Bowen Weng · Ningbo University2 papers (2022–2023) · 2 papers (2013–2015)Zhengxiao Du · Tsinghua University1 papers (2023–2023)Géraldine Gebhart · European Institute of Oncology1 papers (2018–2018)Linwei Duan · Guangxi University1 papers (2021–2021)Jonathan Corren · APLA Health1 papers (2015–2015)Nicola A. Hanania · Baylor College of Medicine1 papers (2015–2015)Yingru Zhao · Xiamen University1 papers (2020–2020) · 1 papers (2015–2015) · 1 papers (2019–2019)